Reply: Pauling, et al., Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Denton, CP; Herrick, AL; (2018) Reply: Pauling, et al., Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis. Arthritis & Rheumatology 10.1002/art.40480 . (In press).

http://ift.tt/2tHPIgg